NCBI PubMed Central
open access
Analysis signals of disproportionate reporting associated with donanemab: A retrospective pharmacovigilance study using the FAERS database.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients#1088524
- Study for Naltrexone on the Abuse Potential of Methylphenidate#851579
- Factors of Potentially Dangerous Drug Interactions in Patients With Cardiovascular Diseases and Multimorbidity#968129
- ALICIA (Acalabrutinib in CLL Therapy)#845329
- Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine#1112884
Record · ID 288847
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive